PharmaShots | Incisive News in 3 Shots

Subscribe Now

EGFR Exon20 Insertion+

The US FDA Grants Priority Review to Takeda's Mobocertinib (TAK-788) for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer

The US FDA Grants Priority Review to Takeda's Mobocertinib (TAK-788) for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Can...

April 28, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us